Herantis Pharma to Participate in the Upcoming Virtual Conferences
Herantis Pharma Plc, Press Release, 3 May 2021 at 14:00 EET Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will hold 1x1 meetings and have a digital company presentation at the following virtual investor conferences. Event Details: Redeye Investor Forum Online Date: 11 May 2021 Bio€quity Europe Dates: 17 – 19 May 2021 ABGSC Life Science Summit Date: 25 May 2021 Presentation Time: 11:00 – 11:30 a.m. CEST / 12:00 – 12:30 EEST All